Counterfeit Medicines Seized in Nationwide Operation
ISLAMABAD — The Drug Regulatory Authority of Pakistan (DRAP) has seized large consignments of counterfeit medicines in a nationwide crackdown, uncovering falsified drugs circulating in the market. Officials confirmed that antibiotics, painkillers, and chronic disease treatments were among the fake medicines tested and found to contain harmful or incorrect formulations.
Public Health and Pharmaceutical Supply Chain Concerns
Authorities warned that counterfeit medicines pose a direct threat to patient safety while undermining the credibility of the pharmaceutical industry. The crackdown has reignited debate over the weaknesses in the pharmaceutical supply chain, where gaps in supply chain management and medicine traceability allow fake products to infiltrate the market.
Technology as a Safeguard: Blockchain and Traceability
Experts argue that stronger supply chain visibility and supply chain traceability are essential. Adopting blockchain technology and smart contracts in pharmaceutical supply chain management could help create a tamper-proof system for drug authentication, medicine serialization, and end-to-end traceability.
Logistics, Warehousing, and 3PL Oversight
Industry leaders say that logistics companies, warehousing operations, and third party logistics (3PL) providers must work closely with regulators to strengthen the flow of legitimate medicines. Deploying advanced supply chain software and inventory management systems could help close loopholes that counterfeit networks exploit.
Consumer Safety and Future Action
DRAP urged the public to remain cautious, advising patients to verify packaging and consult healthcare professionals if they suspect counterfeit products. Officials promised to expand enforcement measures and enhance supply chain transparency in Pakistan, ensuring that only authentic medicines reach consumers.
🔗 Reference: Nation Pakistan — DRAP seizes counterfeit medicines in nationwide crackdown